Research Topics
| D C GoffSummaryAffiliation: Wake Forest University School of Medicine Country: USA Publications
| Collaborators
|
Detail Information
Publications
Knowledge of heart attack symptoms in a population survey in the United States: The REACT Trial. Rapid Early Action for Coronary TreatmentD C Goff
Wake Forest University School of Medicine, Winston Salem, NC 27157 1063, USA
Arch Intern Med 158:2329-38. 1998..Deficiencies in knowledge of symptoms may contribute to delay and could be a target for intervention. We sought to characterize symptom knowledge...
Prehospital delay in patients hospitalized with heart attack symptoms in the United States: the REACT trial. Rapid Early Action for Coronary Treatment (REACT) Study GroupD C Goff
Wake Forest University School of Medicine, Winston Salem, NC 27157 1063, USA
Am Heart J 138:1046-57. 1999..The use of thrombolytic therapy for patients with myocardial infarction has been limited by patient delay in seeking care. We sought to characterize prehospital delay in patients hospitalized for evaluation of heart attack symptoms...
Congestive heart failure in the United States: is there more than meets the I(CD code)? The Corpus Christi Heart ProjectD C Goff
Department of Public Health Science, Wake Forest University School of Medicine, Winston Salem, NC 27157 1063, USA
Arch Intern Med 160:197-202. 2000..Congestive heart failure (CHF) is increasing as a public health problem in the United States. The ability to quantify this problem has been limited by a lack of data regarding the validity of CHF identification...
The combination oral and nutritional treatment of late-onset diabetes mellitus (CONTROL DM) trial resultsD M Reboussin
Department of Public Health Sciences, Wake Forest University School of Medicine, Winston Salem, NC 27157 1063, USA
Diabet Med 21:1082-9. 2004..To examine the effect of short-term improvements in glycaemic control on brachial artery endothelial function as a marker of cardiovascular health...
Investigating correlates of health related quality of life in a low-income sample of patients with diabetesF Camacho
Department of Public Health Sciences, Wake Forest University School of Medicine, Medical Center Boulevard, Winston Salem, NC 27157 1063, USA
Qual Life Res 11:783-96. 2002..We sought to describe and find correlates of health-related quality of life among under-served low-income patients in North Carolina with diabetes mellitus...
Coronary artery calcium quantification with retrospectively gated helical CT: protocols and techniquesJ J Carr
Department of Radiology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157 1088, USA
Int J Cardiovasc Imaging 17:213-20. 2001..The development and initial experience of cardiac gating with multidetector CT systems is presented...
Quality of diabetes care among low-income patients in North CarolinaR A Bell
Department of Public Health Sciences, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157, USA
Am J Prev Med 21:124-31. 2001..The purpose of this study is to examine the level of diabetes care among low-income populations in North Carolina...
Lipoprotein concentrations and carotid atherosclerosis by diabetes status: results from the Insulin Resistance Atherosclerosis StudyD C Goff
Department of Public Health Sciences, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157, USA
Diabetes Care 23:1006-11. 2000..The relative strength of these associations could differ by diabetes status as a result of diabetes-related lipoprotein modifications...
Trends in severity of hospitalized myocardial infarction: the atherosclerosis risk in communities (ARIC) study, 1987-1994D C Goff
Wake Forest University School of Medicine, Winston Salem, NC 27157 1063, USA
Am Heart J 139:874-80. 2000..Declining mortality rates of coronary heart disease in the United States could be attributable to declining incidence, declining severity, and/or improvements in treatment...
Constructing common cohorts from trials with overlapping eligibility criteria: implications for comparing effect sizes between trialsDavid L Mount
Wake Forest University School of Medicine, Winston Salem, NC, USA
Clin Trials 6:416-29. 2009..Comparing findings from separate trials is necessary to choose among treatment options, however differences among study cohorts may impede these comparisons...
Birth cohort evidence of population influences on blood pressure in the United States, 1887-1994D C Goff
Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1063, USA
Ann Epidemiol 11:271-9. 2001..S. population during the period 1887 through 1975. This epidemiologic analysis indicates that population-wide influences can alter favorably the distribution of BP throughout the whole population...
Effects of intensive glucose lowering in type 2 diabetesHertzel C Gerstein
N Engl J Med 358:2545-59. 2008..These findings identify a previously unrecognized harm of intensive glucose lowering in high-risk patients with type 2 diabetes. (ClinicalTrials.gov number, NCT00000620.)..
A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophreniaD C Goff
Psychiatry Service, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts, USA
J Clin Psychopharmacol 21:484-7. 2001..These preliminary results suggest that CX516 and other "ampakines" hold promise for the treatment of schizophrenia...
Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinationsO Freudenreich
MGH Schizophrenia Program, Massachusetts General Hospital, Boston, MA, USA
Acta Psychiatr Scand 106:323-30. 2002..To review the literature on efficacy and risks of combining antipsychotics (atypical with atypical or conventional) and suggest a rationale and strategies for future clinical trials...
An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophreniaD C Henderson
Schizophrenia Program, Massachusetts General Hospital, Boston, MA, USA
Acta Psychiatr Scand 113:142-7. 2006..We conducted this 6-week open-label trial to examine the effects of adjunctive aripiprazole in clozapine-treated subjects on weight, lipid and glucose metabolism, as well as positive and negative symptoms of schizophrenia...
